{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T21:19:18Z","timestamp":1722892758769},"reference-count":49,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Although the U.S. National Academy of Sciences concluded that anthrax vaccine adsorbed (AVA) has an adverse event (AE) profile similar to those of other adult vaccines, 30 to 70% of queried AVA vaccinees report AEs. AEs appear to be correlated with certain demographic factors, but the underlying immunologic pathways are poorly understood. We evaluated a cohort of 2,421 AVA vaccinees and found 153 (6.3%) reported an AE. Females were more likely to experience AEs (odds ratio [OR] = 6.0 [95% confidence interval {CI} = 4.2 to 8.7];\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001). Individuals 18 to 29 years of age were less likely to report an AE than individuals aged 30 years or older (OR = 0.31 [95% CI = 0.22 to 0.43];\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001). No significant effects were observed for African, European, Hispanic, American Indian, or Asian ancestry after correcting for age and sex. Additionally, 103 AEs were large local reactions (LLRs), whereas 53 AEs were systemic reactions (SRs). In a subset of our cohort vaccinated 2 to 12 months prior to plasma sample collection (\n            <jats:italic>n<\/jats:italic>\n            = 75), individuals with LLRs (\n            <jats:italic>n<\/jats:italic>\n            = 33) had higher protective-antigen (PA)-specific IgE levels than matched, unaffected vaccinated individuals (\n            <jats:italic>n<\/jats:italic>\n            = 50;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.01). Anti-PA IgE was not associated with total plasma IgE, hepatitis B-specific IgE, or anti-PA IgG in individuals who reported an AE or in matched, unaffected AVA-vaccinated individuals. IP-10 was also elevated in sera of individuals who developed LLRs (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.05). Individuals reporting SRs had higher levels of systemic inflammation as measured from C-reactive protein (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.01). Thus, LLRs and SRs are mediated by distinct pathways. LLRs are associated with a vaccine-specific IgE response and IP-10, whereas SRs demonstrate increased systemic inflammation without a skewed cytokine profile.\n          <\/jats:p>","DOI":"10.1128\/cvi.00092-16","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T04:00:05Z","timestamp":1465444805000},"page":"664-671","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination"],"prefix":"10.1128","volume":"23","author":[{"given":"Lori","family":"Garman","sequence":"first","affiliation":[{"name":"Oklahoma Medical Research Foundation, Department of Arthritis and Clinical Immunology, Oklahoma City, Oklahoma, USA"},{"name":"Oklahoma University Health Science Center, Department of Microbiology and Immunology, Oklahoma City, Oklahoma, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Smith","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation, Department of Arthritis and Clinical Immunology, Oklahoma City, Oklahoma, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily E.","family":"Muns","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation, Department of Arthritis and Clinical Immunology, Oklahoma City, Oklahoma, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy A.","family":"Velte","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation, Department of Arthritis and Clinical Immunology, Oklahoma City, Oklahoma, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina E.","family":"Spooner","sequence":"additional","affiliation":[{"name":"Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa E.","family":"Munroe","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation, Department of Arthritis and Clinical Immunology, Oklahoma City, Oklahoma, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Darise","family":"Farris","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation, Department of Arthritis and Clinical Immunology, Oklahoma City, Oklahoma, USA"},{"name":"Oklahoma University Health Science Center, Department of Microbiology and Immunology, Oklahoma City, Oklahoma, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata J. M.","family":"Engler","sequence":"additional","affiliation":[{"name":"Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"James","sequence":"additional","affiliation":[{"name":"Oklahoma Medical Research Foundation, Department of Arthritis and Clinical Immunology, Oklahoma City, Oklahoma, USA"},{"name":"Oklahoma University Health Science Center, Department of Microbiology and Immunology, Oklahoma City, Oklahoma, USA"},{"name":"Oklahoma University Health Science Center, Departments of Medicine and Pathology, Oklahoma City, Oklahoma, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63697-8"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.12.4566-4567.2001"},{"key":"e_1_3_3_4_2","first-page":"1","article-title":"The impact of anthrax attacks on the American public","volume":"4","author":"Blendon RJ","year":"2002","unstructured":"Blendon RJ, Benson JM, DesRoches CM, Pollard WE, Parvanta C, Herrmann MJ. 2002. The impact of anthrax attacks on the American public. MedGenMed 4:1.","journal-title":"MedGenMed"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0706.010604"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2006.03112.x"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2009.08.006"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00969.x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2888-2893.2001"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.6.3471-3477.2004"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(91)90237-Z"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.1.394-398.2006"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00469-14"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.13.1532"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.04.025"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00387-5"},{"key":"e_1_3_3_17_2","first-page":"762","article-title":"Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database","volume":"51","author":"Geier MR","year":"2004","unstructured":"Geier MR, Geier DA. 2004. Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Hepatogastroenterology 51:762\u2013767.","journal-title":"Hepatogastroenterology"},{"key":"e_1_3_3_18_2","first-page":"341","article-title":"Surveillance for adverse events associated with anthrax vaccination\u2014U.S. Department of Defense, 1998-2000","volume":"49","author":"CDC","year":"2000","unstructured":"CDC. 2000. Surveillance for adverse events associated with anthrax vaccination\u2014U.S. Department of Defense, 1998-2000. MMWR Morb Mortal Wkly Rep 49:341\u2013345.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00435-3"},{"key":"e_1_3_3_20_2","first-page":"10","article-title":"Vaccine allergy and pseudo-allergy","volume":"13","author":"Ponvert C","year":"2003","unstructured":"Ponvert C, Scheinmann P. 2003. Vaccine allergy and pseudo-allergy. Eur J Dermatol 13:10\u201315.","journal-title":"Eur J Dermatol"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.039"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0810.020380"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.38573"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2005.03.005"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2009.09.001"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/653495"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.6.3276-3283.2004"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00788-08"},{"key":"e_1_3_3_29_2","first-page":"334","article-title":"IgE synthesis in man. I","volume":"118","author":"Nagel J","year":"1977","unstructured":"Nagel J, Svec D, Waters T, Fireman P. 1977. IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (Td) toxoids. J Immunol 118:334\u2013341.","journal-title":"Development of specific IgE antibodies after immunization with tetanus-diphtheria (Td) toxoids. J Immunol"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237376"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000236967"},{"key":"e_1_3_3_32_2","first-page":"238","article-title":"Vaccine hypersensitivity-update and overview","volume":"140","author":"Fritsche PJ","year":"2010","unstructured":"Fritsche PJ, Helbling A, Ballmer-Weber BK. 2010. Vaccine hypersensitivity-update and overview. Swiss Med Wkly 140:238\u2013246.","journal-title":"Swiss Med Wkly"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2104"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2010.24.3386"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.936"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000058345.05741.6b"},{"key":"e_1_3_3_37_2","first-page":"12","volume-title":"Adverse effects of vaccines: evidence and causality","author":"Committee to Review Adverse Effects of Vaccines, Institute of Medicine","year":"2011","unstructured":"Committee to Review Adverse Effects of Vaccines, Institute of Medicine 2011. Evaluating biological mechanisms of adverse events, p 12\u201314. In Stratton K, Ford A, Rusch E, Clayton EW (ed), Adverse effects of vaccines: evidence and causality. National Academies Press, Washington, DC."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922202753519142"},{"key":"e_1_3_3_39_2","first-page":"980","article-title":"IgE against HIV proteins in clinically healthy children with HIV disease","volume":"98","author":"Secord FA KG","year":"1996","unstructured":"Secord FA KG, Auci DL, Smith-Norowitz T, Chice S, Finkielstein A, Nowakowski M, Fikrig S, Durkin HG. 1996. IgE against HIV proteins in clinically healthy children with HIV disease. J Allergy Clin Immunol 98:980\u2013984.","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.08.001"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jlb.61.3.246","article-title":"Mig and IP-10: CXC chemokines that target lymphocytes","volume":"61","author":"Farber JM","year":"1997","unstructured":"Farber JM. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61:246\u2013257.","journal-title":"J Leukoc Biol"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.4.1084"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1141"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425885"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01208-08"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001199"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.05.054"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.096"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-013-1946-2"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.05.035"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00092-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00092-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T01:09:35Z","timestamp":1622077775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00092-16"}},"subtitle":[],"editor":[{"given":"P. P.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1128\/CVI.00092-16"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00092-16","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"2016-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}